^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CARv3-TEAM-E T cells

    i
    Other names: CARv3-TEAM-E T cells
    Associations
    News
    Trials
    Company:
    Massachusetts General Hospital
    Drug class:
    EGFRvIII-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials